The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGusbourne Regulatory News (GUS)

Share Price Information for Gusbourne (GUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.50
Bid: 58.00
Ask: 61.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.172%)
Open: 59.50
High: 59.50
Low: 59.50
Prev. Close: 59.50
GUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Refinancing of existing loan facilities

19 Jan 2024 16:20

RNS Number : 3512A
Gusbourne PLC
19 January 2024

Friday 19 January 2024

Gusbourne PLC

("Gusbourne or the Company")

New long-term deep discount bond

Refinancing of existing loan facilities

Gusbourne Plc, (AIM: GUS) the English sparkling wine producer today announces that it has completed a refinancing of its debt arrangements which were held with PNC Financial Services UK Ltd ("PNC") and a company associated with Lord Ashcroft through the issue of a new £20m long-term secured deep discount bond (the "Refinancing"), providing additional funding for future growth.

Background to the Refinancing

On 15 August 2022, the Company announced that it had increased its existing £10.5 million 5-year asset-based lending facilities by an additional £6 million to provide the Company with a total £16.5 million asset-based lending facilities with PNC ("PNC Facility") structured as a revolving loan facility. The PNC Facility carried interest at the annual rate of 2.50 per cent over the Bank of England Base Rate (the latest interest rate being 7.75%) and was payable monthly, with security by way of first priority charges over the Company's inventory, receivables and freehold property as well as an all-assets debenture, and contained financial and general covenants and customary events of default.

On 14 November 2023, the Company announced that it had agreed a short-term unsecured loan facility of £1.5m with a company associated with Lord Ashcroft ("Loan"). The Loan carried interest at the annual rate of 2.50 per cent over the Bank of England Base Rate and was repayable on demand.

The Refinancing

The Company has now entered into an agreement with a company associated with Lord Ashcroft (Moongate Holdings Group Limited) for the issue of a new £20m long-term secured deep discount bond ("DDB") to support the Company's working capital and ongoing growth.

The subscription price of the DDB is £20m. The subscription proceeds of £20m have been used to repay the existing PNC Facility amounting to £16.3m, repay the short-term unsecured Loan of £1.5m, related fees and expenses of £0.6m and the remaining proceeds will be used for working capital and to support the ongoing growth strategy of the Company.

Key terms of the DDB:

· Issued at a discount of 7.75% per annum on quarterly rests;

· Nominal amount is £26.3m which is payable on the final redemption date of 12 August 2027, which end date is consistent with the PNC Facility;

· Early redemption of the DDB with not less than 90 days' notice (with early repayment fees);

· Accrued discount is payable on the early or final redemption of the DDB - allowing increased cash flow for the Company versus monthly interest repayments;

· Security over land, properties and stock, full fixed and floating security over the assets of both the Company and Gusbourne Estate Limited;

· Other key terms and conditions of the DDB are consistent with the PNC Facility.

Jim Ormonde, Chairman, said:

"The Board are pleased to announce the new long-term funding and are very appreciative of the continued support of the major shareholder to underpin the Company's growth strategy."

Related Party Transaction

Lord Ashcroft holds an interest in 66.3% of the Company's ordinary shares of 1 pence each and is a Substantial Shareholder in the Company as defined by the AIM Rules for Companies ("AIM Rules"). The issuance of the DDB constitutes a related party transaction pursuant to AIM Rule 13. The independent directors of the Company for the purposes of the Refinancing, having consulted with the Company's nominated adviser, Panmure Gordon, consider that the terms of the DDB are fair and reasonable insofar as shareholders are concerned.

Board appointment confirmation

Further to the Company's announcement on 17 January 2024 Gusbourne confirms that regulatory due diligence has now been completed and as a result Jonathan White and Simon Bradbury are appointed as executive directors of the Company, as Chief Executive Officer and Chief Commercial Officer respectively, effective immediately.

In accordance with the AIM Rules the following information is required to be disclosed in relation to both Mr White and Mr Bradbury:

Schedule 2(g) disclosures

Jonathan Michael Garry White (aged 42) holds the following directorship:

Birch Meadow Management Company Limited

Mr White does not own any shares in the Company, has no previous directorships and has confirmed there is no further information to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules for Companies.

Simon William Bradbury (aged 56) held the following previous directorship:

SWB Drinks Consulting Ltd

Mr Bradbury owns 2,600 shares in the Company, has no current directorships and has confirmed there is no further information to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules for Companies.

Enquiries:

Gusbourne Plc

Jonathan White, CEO

Katharine Berry, CFO

+44 (0)12 3375 8666

Phil Clark, Investor Relations

Panmure Gordon (UK) Limited (Nomad and Sole Broker)

James Sinclair-Ford / Ailsa Macmaster / Lauren Riley

+44 (0)20 7886 2500

Hugh Rich / Rauf Munir

Media

Kate Hoare / Ben Robinson / India Spencer (Houston)

gusbourne@houston.co.uk

+44 (0)20 4529 0549

Note: This and other press releases are available at the Company's website: www.gusbourneplc.com

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

Note to Editors

Gusbourne produces and distributes a range of high quality and award winning vintage English sparkling wines from grapes grown in its own vineyards in Kent and West Sussex.

The Gusbourne business was founded by Andrew Weeber in 2004 with the first vineyard plantings at Appledore in Kent. The first wines were released in 2010 to critical acclaim. Following additional vineyard plantings in 2013 and 2015 in both Kent and West Sussex, Gusbourne now has 93 hectares of mature vineyards. The NEST visitor centre was opened next to the winery in Appledore in 2017, providing tours, tastings and a direct outlet for our wines.

Right from the beginning, Gusbourne's intention has always been to produce the finest English sparkling wines. Starting with carefully chosen sites, we use best practice in establishing and maintaining the vineyards and conduct green harvests to ensure we achieve the highest quality grapes for each vintage. A quest for excellence is at the heart of everything we do. We blind taste hundreds of samples before finalising our blends and even after the wines are bottled, they spend extended time on their lees to add depth and flavour. Once disgorged, extra cork ageing further enhances complexity. Our winemaking process remains traditional, but one that is open to innovation where appropriate. It takes four years to bring a vineyard into full production and a further four years to transform those grapes into Gusbourne's premium sparkling wine.

Gusbourne's luxury brand enjoys premium price positioning and is distributed in the finest establishments both in the UK and abroad. Our wines can be found in leading luxury retailers, restaurants, hotels and stockists, always being aware that where we are says a lot about who we are.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IODQKCBDABKDODD
Date   Source Headline
31st Jan 20247:00 amRNSTrading Statement
19th Jan 20244:20 pmRNSRefinancing of existing loan facilities
17th Jan 20247:00 amRNSBoard Changes and CEO Designate Appointment
4th Jan 202412:26 pmRNSIssue of Equity
21st Dec 20237:00 amRNSAuditor Change
30th Nov 20237:00 amRNSDirectorate Change
14th Nov 20237:00 amRNSShort term Unsecured Loan & Extension of Warrants
3rd Nov 20233:00 pmRNSIssue of Equity
26th Oct 20237:00 amRNSWarrant Exercise/PDMR Dealings
19th Oct 20237:00 amRNSHarvest Report
28th Sep 20237:00 amRNSInterim results to 30 June 2023
6th Sep 20237:00 amRNSBoard Change and Appointment of Interim CEO
1st Sep 20237:00 amRNSIssue of Equity
29th Jun 20232:42 pmRNSResult of AGM
27th Jun 20237:00 amRNSBoard Change
7th Jun 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSDirectorate Change
14th Feb 202312:12 pmRNSAIM Rule 17 Notification
31st Jan 20237:00 amRNSTrading Update
16th Jan 20231:32 pmRNSIssue of Equity
20th Dec 20227:00 amRNSGrant of Share Options
16th Dec 202210:30 amRNSIssue of Equity
14th Dec 20227:00 amRNSExtension of the final exercise date of Warrants
27th Oct 20227:00 amRNSHarvest Report
4th Oct 20221:51 pmRNSIssue of Equity
29th Sep 20227:00 amRNSInterim results to 30 June 2022
6th Sep 20227:00 amRNSChange of Adviser
22nd Aug 20227:00 amRNSDirectorate Change
15th Aug 20227:00 amRNSTrading Update, Refinancing & Land Purchase
30th Jun 20222:00 pmRNSResult of AGM
6th Jun 20227:00 amRNSFinal Results
3rd May 202210:15 amRNSIssue of Equity
29th Mar 202212:10 pmRNSIssue of Equity
2nd Mar 20229:30 amRNSIssue of Equity
10th Feb 20227:00 amRNSTrading Update
17th Dec 20217:00 amRNSCompletion of Warrant Issue
15th Dec 20213:50 pmRNSFurther re Issue of Warrants
15th Dec 20217:00 amRNSResult of Open Offer and Issue of Warrants
22nd Nov 20217:00 amRNSLaunch of Open Offer and Posting of Circular
2nd Nov 20214:34 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSResult of Warrant Exercise and Debt Conversion
18th Oct 20214:30 pmRNSApplication for Admission
18th Oct 20212:10 pmRNSResult of ABB
18th Oct 20217:01 amRNSPlacing and Subscription
18th Oct 20217:00 amRNSFunding Update
30th Sep 20217:00 amRNSInterim Results to 30 June 2021
10th Aug 20217:38 amRNSIssue of Equity
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSTrading and Capital Structure Update
19th Jul 20211:00 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.